A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease
Clinical trial NCT07284381 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07284381
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-15
- Primary completion
- 2026-08-01
- Enrollment
- 261
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.